Netherlands· NL-6bb53a461217
Combodart 0,5 mg/0,4 mg, harde capsules
A tamsulosin and dutasteride product containing dutasteride + tamsulosinehydrochloride, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tamsulosin and dutasteride is registered in 13 of 19 countries.
Countries holding a registration under ATC G04CA52 (tamsulosin and dutasteride), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Tamsulosin and dutasteride · ATC G04CA52
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DUTASTERIDE + TAMSULOSINEHYDROCHLORIDE
- Manufacturer
- Medcor Pharmaceuticals B.V.
- Country
- Netherlands (NL)
- ATC code
- G04CA52
- ATC class
- Tamsulosin and dutasteride
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id128295//104130
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for tamsulosin and dutasteride.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tamsulosin and dutasteride · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Tamsulosin and dutasteride in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADATAMAdamed Pharma S.A., Czosnów
- SpainBIDUTAM 0,5 MG/0,4 MG CAPSULAS DURAS EFGLaboratorios Q Pharma S.L.
- United KingdomCombodart 0.5mg/0.4mg capsulesRecordati Pharmaceuticals Ltd
- GermanyDuodartGlaxosmithkline Gmbh & Co. Kg
- PolandAdatam DuoAdamed Pharma S.A.
- SwitzerlandDuodart
- FinlandDuodartGlaxoSmithKline Oy
- FranceCOMBODART 0,5 mg/0,4 mg, géluleGLAXOSMITHKLINE
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Dutaglandin Comp., Dutamsul
- Belgium · Combodart, Dutasteride/Tamsulosine Eg
- Bulgaria · Агландин Комп, Дуодарт
- Cyprus · Dinaplex, Duodart
- Czechia · Adatam, Aglandut
- Germany · Duodart, Duta-Tamsaxiro
- Denmark · Duta Tamsaxiro, Dutasterid/Tamsulosinhydrochlorid G.L. Pharma
- Estonia · Combodart, Dutasteride/Tamsulosin Olpha
- Spain · Bidutam, Duodart
- Finland · Duodart, Dutasterid/Tamulosin Stada
- France · Combodart, Dutasteride/Tamsulosine Accord
- United Kingdom (Northern Ireland) · Combodart, Dutasteride/Tamsulosin Hydrochloride Accord Healthcare
- Greece · Dinaplex, Doxared
- Croatia · Atekago, Duitam
- Hungary · Aglandin, Duodart
- Ireland · Combodart, Dutasteride/Tamsulosin Hydrochloride Accord Healthcare Ireland
- Iceland · Duodart, Duta Tamsaxiro
- Italy · Anasso, Combodart
- Lithuania · Aduzin, Combodart
- Luxembourg · Combodart, Dutasterid/Tamsulosin Ratiopharm
- Latvia · Combodart, Dutasteride/Tamsulosin Olpha
- Malta · Atucare, Combodart
- Norway · Duodart, Dutasterid/Tamsulosin Teva
- Poland · Duitam, Duodart
- Portugal · Combodart, Dutasterida + Tansulosina Accord
- Romania · Duodart, Dutasteridă / Tamsulosin
- Slovenia · Amdut Combo, Combodart
- Slovakia · Adatam, Aglandin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4e18883d-868f-4dc2-aed6-618846b32933 GET /v1/drugs/4e18883d-868f-4dc2-aed6-618846b32933?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h104130_smpc.pdf",
"strength": null,
"atc_label": "Tamsulosin and dutasteride",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128295",
"excipients": [
"AMMONIA (E 527)",
"BUTYLHYDROXYTOLUEEN (E 321)",
"CARNAUBAWAS (E 903)",
"CARRAGEENAN (E 407)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)",
"GELATINE (E 441)",
"GLYCEROL (E 422)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"IJZEROXIDE GEEL (E 172)",
"IJZEROXIDE ROOD (E 172)",
"IJZEROXIDE ZWART (E 172)",
"KALIUMCHLORIDE (E 508)",
"KALIUMHYDROXIDE (E 525)",
"LECITHINE (E 322)",
"MAÏSZETMEEL",
"MONO- EN DIGLYCERIDEN VAN VETZUREN, MIDDENLANGE KETEN (E 471)",
"NATRIUMLAURILSULFAAT",
"POLYSORBAAT 80 (E 433)",
"PROPYLEENGLYCOL (E 1520)",
"SCHELLAK (E 904)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)",
"TITAANDIOXIDE (E 171)",
"TRIETHYLCITRAAT (E 1505)",
"TRIGLYCERIDEN MIDDELLANGE KETEN",
"ZONNEGEEL FCF (E 110)",
"ZWARTE INKT"
],
"substances": [
"DUTASTERIDE",
"TAMSULOSINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128295.pdf",
"authorised_at": "2021/06/08",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "128295//104130",
"additional_monitoring": "N"
}See everything about tamsulosin and dutasteride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.